Analysis Tools|
Allele Symbol Allele Name Allele ID |
Mmp11tm1Mrio targeted mutation 1, Marie-Christine Rio MGI:2387934 |
||||||||||||||||
| Summary |
3 genotypes
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• lower death rate and a reduced number and size of DMBA-induced carcinomas
|
|
• lower death rate and a reduced number and size of DMBA-induced carcinomas
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• exhibit significantly enhanced neointimal formation 2-3 weeks after electric injury of the femoral artery compared to wild-type
|
|
• exhibit significantly enhanced neointimal formation 2-3 weeks after electric injury of the femoral artery compared to wild-type
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• all mutants developed mammary gland tumors however the average age of tumor onset was 37 weeks compared to 25 weeks in control transgenic mice that are wildtype for Mmp11
• mean time required to develop detectable tumor after the first pregnancy was about 10 weeks longer than in control transgenic mice that are wildtype for Mmp11
• decreased invasive primary tumor incidence compared to control transgenic mice that are wildtype for Mmp11
|
|
• 69% developed lung metastases compared to 31% of control transgenic mice that are wildtype for Mmp11
• higher total number of metastases compared to transgenic mice that are wildtype for Mmp11
|
|
• mean tumor number per mouse was about 40% lower than in control transgenic mice that are wildtype for Mmp11
• mean total tumor volume was about 2-fold lower than in control transgenic mice that are wildtype for Mmp11
|
|
• developed tumors of various sizes that corresponded to moderately to poorly differentiated invasive duct carcinomas with most tumors growing as solid areas that contained no stroma
|
|
• all mutants developed mammary gland tumors however the average age of tumor onset was 37 weeks compared to 25 weeks in control transgenic mice that are wildtype for Mmp11
• mean time required to develop detectable tumor after the first pregnancy was about 10 weeks longer than in control transgenic mice that are wildtype for Mmp11
• decreased invasive primary tumor incidence compared to control transgenic mice that are wildtype for Mmp11
|
|
• all mutants developed mammary gland tumors however the average age of tumor onset was 37 weeks compared to 25 weeks in control transgenic mice that are wildtype for Mmp11
• mean time required to develop detectable tumor after the first pregnancy was about 10 weeks longer than in control transgenic mice that are wildtype for Mmp11
• decreased invasive primary tumor incidence compared to control transgenic mice that are wildtype for Mmp11
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/12/2024 MGI 6.24 |
|
|
|
||
